7. Sexualidad. Uroginecología

Clickee sobre el título del trabajo para acceder al mismo

7.1. Salud sexual en la mujer climatérica.

7.1.1 Sexual disfunction in menopause 2013 (1.97 MB)

7.1.2 Sexual fuction in women with breast cancer 2012 (190 KB)

7.1.3 Sexual function in elderly women 2012 (773 KB)

7.1.4 Sexual function in menopausal age. 2013 (315 KB)

7.1.5 Sexual life in postmenopausal. 2009 (597 KB)

7.1.6 Sexuality in midlife 2012 (464 KB)

7.1.7 Testosterone and buspirone 2014 (667 KB)

7.1.8 Testosterone and phosphodiesterase 2014 (741 KB)

7.1.9 Spanish consensus on sexual health over 50 2014 (779 KB)

7.1.10 Androgen in women 2013 (156 KB)

7.1.11 Manteining sexuality in menopause (193 KB)

7.1.12 Menopause and sexuality 2015

7.1.13 Las concentraciones séricas de esteroides permanecen dentro de valores normales en la postmenopausia en mujeres que recibieron diariamente 6 mg de prasterona intravaginal por 12 semanas

7.1.14 Eficacia de la dehidroepiandrosterona intravaginal (DHEA) en la dispareunia severa, la sequedad vaginal, los síntomas de atrofia vulvovaginal y el síndrome genitourinario de la menopausia

7.2. Infección urinaria recurrente en la mujer menopáusica. Manejo clínico. Rol de las nuevas vacunas.

7.2.1 E coli vaccine in urinary infections 2013 (940 KB)

7.2.2 Immunoactive prophylaxis 2009 (120 KB)

7.2.3 Urinary tract infections 2013 (238 KB)

7.2.4 Urinary tract infections in postmenopause 2011 (268 KB)

7.2.5 Urological infections UROWEB 2013 (1.00 MB)

7.2.6 Vaccine for urinary infections 2013 (228 KB)

7.2.7 Genitoutinay syndrome of menopause 2015

7.2.8 Urinary tract infections in women with stress urinary incontinence treated with transobturator suburethral tape and benefit gained from the sublingual polibacterial vaccine 2015

7.2.9. Prevención de infecciones Urinarias en la post menopausia sin antibióticos.

7.3. Manejo de la incontinencia urinaria y del prolapso genital: nuevas terapéuticas.

7.3.1 Biofeedback review 2012 (485 KB)

7.3.2 Estrogen and incident urinary incontinence among postmenopausal women. 2012 (307 KB)

7.3.3 Genitourinay sindrome of menopause New terminology 2014 (176 KB)

7.3.4 NAMS Vulvovaginal atrophy 2013 (191 KB)

7.3.5 Nonsurgical Management of Urinary Incontinence in Women ACP 2014 (233 KB)

7.3.6 Nonsurgical treatments ofurinary incontinence 2012 (12.3 MB)

7.3.7 Oestrogen therapy for urinary incontinence in post-menopausal women Cochrane 2012 (1.32 MB)

7.3.8 Overcactive bladder in women 2012 (213 KB)

7.3.9 Pelvic floor 2008 (2.16 MB)

7.3.10 Prolapso genital SEGO (314 KB)

7.3.11 Prolapso urogenital 2008 (201 KB)

7.3.12 Urinary incontinence 2013 (843 KB)

7.3.13 Urinary Incontinence 2014 UROWEB (667 KB)

7.3.14 Urinary incontinence 2014 (1.12 MB)

7.3.15 Urinary incontinence surgery 2012 (43.3 KB)

7.3.16 Walters prolapso de Cúpula 2013 (2.40 MB)

7.3.17 Local Oestrogen for Pelvic Floor Disorders: Review 2015

7.4. Cirugía cosmética genital.

7.4.1 Aestethic surgery for female genitalia 2012 (481 KB)

7.4.2 Cosmetic outcomes in women 2011 (544 KB)

7.4.3 Female genital cosmetic surgery 2010 (407 KB)

7.4.4 Female genital cosmetic surgery 2013 (590 KB)

7.4.5 Female genital cosmetic surgery Review 2011 (1.20 MB)

7.5. Vulvodinia.

7.5.1 Vulvodinia